Skip navigation
Menu
Medical & Pharma Meetings>Continuing Medical Education

How New State Pharma Marketing Laws Could Affect Continuing Medical Education

From California to Massachusetts, states are implementing laws that regulate how pharma and medical device companies interact with physicians.

A flood of new state laws now strictly regulates pharmaceutical and medical device companies' interactions with healthcare professionals, and more are on the way. Unlike the Pharmaceutical Research and Manufacturers of America and AdvaMed codes on interactions with healthcare professionals, which are voluntary, these state laws include fines and penalties for noncompliance. And now Congress is considering the Physician Payments Sunshine Act of 2009, which would also require that aggregate

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Become a member for free
TAGS: Medical & Pharma Meetings
Hide comments

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
RECOMMENDED FOR YOU
GettyImages-620005846.jpg
Five Takeaways for Planners from the Revised AdvaMed Code
Jun 15, 2022
MM-Array.jpg
Array Launches New Audience Engagement Measurement Tool
Nov 17, 2021
wine-g9f5e7eae9_640.jpg
Some HCP Meetings Going Dry in 2022
Oct 20, 2021
medical_meetings.jpg
What HCPs Crave: Content and Interaction
Aug 19, 2020